This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Discover why allocating more bonds as you age can stabilize withdrawals and protect capital. A brief primer on safer retirement strategies.
27,889 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Oklo has shed 28% over the past month as investors rotate away from pre-revenue nuclear developers. Utilities remain ...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
Viant DSP is navigating a fast-changing ad-tech landscape in 2026. This analysis breaks down Q1 dynamics, what the nu...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
Zillow has fallen hard, but the question for investors is whether a comeback is plausible. This guide breaks down the...
A growing number of patients are bringing AI into therapy sessions, prompting psychologists to navigate new opportuni...
A CEO of a roughly $5 billion software company says he goes beyond listed references, seeking unlisted sources to ass...